Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.06405
-0.0070 (-9.79%)
Sep 4, 2026, 3:21 PM EST
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $405.8 thousand as of September 4, 2026. Its market cap has increased by 38.40% in one year.
Market Cap
405.80K
Enterprise Value
1.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 405.80K, a decrease of -99.76%. That is a compound annual growth rate of -39.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 405.80K | -23.23% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nextel Medical | 552.41K |
| THC Farmaceuticals | 505.87K |
| inTerra Resources | 458.51K |
| Mosaic ImmunoEngineering | 441.77K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| Sorrento Therapeutics | 326.23K |
| CNBX Pharmaceuticals | 321.15K |